POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 106 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $518,499 | -50.7% | 77,736 | -33.0% | 0.00% | -50.0% |
Q2 2023 | $1,051,440 | +158.8% | 116,053 | +107.7% | 0.00% | +100.0% |
Q1 2023 | $406,305 | -9.1% | 55,888 | -8.8% | 0.00% | 0.0% |
Q4 2022 | $446,898 | -5.9% | 61,303 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $475,000 | – | 61,523 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,909,960 | $19,409,433 | 3.54% |
JOHNSON & JOHNSON | 1,000,000 | $6,670,000 | 2.46% |
BVF INC/IL | 10,563,748 | $70,460,199 | 1.90% |
SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,354,122 | 1.16% |
Boxer Capital, LLC | 2,500,000 | $16,675,000 | 0.89% |
Pier Capital, LLC | 732,936 | $4,888,683 | 0.79% |
Deep Track Capital, LP | 2,781,565 | $18,553,039 | 0.72% |
PFM Health Sciences, LP | 1,613,516 | $10,762,152 | 0.51% |
Eagle Health Investments LP | 306,142 | $2,041,967 | 0.45% |
Onex Canada Asset Management Inc. | 772,905 | $5,155,276 | 0.40% |